Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 402

    1.

    Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.

    Costacou T, Ferrell RE, Orchard TJ.

    Diabetes. 2008 Jun;57(6):1702-6. Epub 2008 Mar 10.PMID: 18332093 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ.

    Diabetes Care. 2003 May;26(5):1374-9.PMID: 12716791 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

    Costacou T, Lopes-Virella MF, Zgibor JC, Virella G, Otvos J, Walsh M, Orchard TJ.

    J Diabetes Complications. 2005 Jul-Aug;19(4):183-93.PMID: 15993351 [PubMed - indexed for MEDLINE]Related articles

    4.

    The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

    Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella MF, Tracy RP, Orchard TJ.

    Diabetologia. 2005 Jan;48(1):41-8. Epub 2004 Dec 23.PMID: 15616802 [PubMed - indexed for MEDLINE]Related articles

    5.

    Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

    Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ.

    Diabetologia. 2007 Nov;50(11):2280-8. Epub 2007 Sep 2.PMID: 17768606 [PubMed - indexed for MEDLINE]Related articles

    6.

    The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.

    Cheurfa N, Dubois-Laforgue D, Ferrarezi DA, Reis AF, Brenner GM, Bouché C, Le Feuvre C, Fumeron F, Timsit J, Marre M, Velho G.

    Diabetes. 2008 Apr;57(4):1063-8. Epub 2008 Jan 11.PMID: 18192542 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

    Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J; LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health).

    Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. Review.PMID: 11258203 [PubMed - indexed for MEDLINE]Related articles

    8.

    The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

    Erbey JR, Kuller LH, Becker DJ, Orchard TJ.

    Diabetes Care. 1998 Apr;21(4):610-4.PMID: 9571351 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.

    Miller RG, Prince CT, Klein R, Orchard TJ.

    Am J Ophthalmol. 2009 Apr;147(4):653-60. Epub 2009 Jan 18.PMID: 19152873 [PubMed - indexed for MEDLINE]Related articles

    10.

    'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease.

    Schaan BD, Quadros AS, Sarmento-Leite R, De Lucca G Jr, Bender A, Bertoluci M.

    Cardiovasc Diabetol. 2007 Jul 25;6:19.PMID: 17651487 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Costacou T, Zgibor JC, Evans RW, Tyurina YY, Kagan VE, Orchard TJ.

    J Diabetes Complications. 2006 Nov-Dec;20(6):387-94.PMID: 17070445 [PubMed - indexed for MEDLINE]Related articles

    12.

    The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men.

    Payne JR, Dhamrait SS, Toor IS, Cooper J, Jones A, Miller GJ, Humphries SE, Montgomery HE.

    Atherosclerosis. 2004 May;174(1):81-6.PMID: 15135254 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates.

    Senior PA, Welsh RC, McDonald CG, Paty BW, Shapiro AM, Ryan EA.

    Diabetes Care. 2005 Apr;28(4):866-72.PMID: 15793187 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes.

    Kretowski A, Hokanson JE, McFann K, Kinney GL, Snell-Bergeon JK, Maahs DM, Wadwa RP, Eckel RH, Ogden LG, Garg SK, Li J, Cheng S, Erlich HA, Rewers M.

    Diabetologia. 2006 Aug;49(8):1946-54. Epub 2006 Jun 13.PMID: 16770585 [PubMed - indexed for MEDLINE]Related articles

    15.

    The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients.

    Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A, Trischitta V.

    Diabetes Care. 2004 Aug;27(8):2015-20.PMID: 15277433 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.

    Pereira AC, Miyakawa AA, Lopes NH, Soares PR, de Oliveira SA, Cesar LA, Ramires JF, Hueb W, Krieger JE.

    Thromb Res. 2007;121(1):25-32. Epub 2007 Jul 2.PMID: 17604826 [PubMed - indexed for MEDLINE]Related articles

    17.

    Coronary artery disease in IDDM. Gender differences in risk factors but not risk.

    Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ.

    Arterioscler Thromb Vasc Biol. 1996 Jun;16(6):720-6.PMID: 8640398 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

    Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV; Strong Heart Study.

    J Am Coll Cardiol. 2002 Dec 4;40(11):1984-90.PMID: 12475459 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.

    Pernod G, Bosson JL, Golshayan D, Barro C, Alloatti S, Turc-Baron C, Quarello F, Jeantet A, Von Albertini B, Forêt M, Lauren G, Cordonnier D, Piccoli G, Wauters JP; Diamant Alpin Collaborative Dialysis Study Group.

    J Nephrol. 2004 Jan-Feb;17(1):66-75.PMID: 15151261 [PubMed - indexed for MEDLINE]Related articles

    20.

    Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Orchard TJ, LLoyd CE, Maser RE, Kuller LH.

    Diabetes Res Clin Pract. 1996 Oct;34 Suppl:S165-71.PMID: 9015687 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data